NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes excessive amounts of proteins that trigger inflammation — called a “cytokine storm” — that can lead to acute respiratory distress syndrome, multiple organ failure and other life-threatening complications.… Read full story

COVID-19 Update: Updated County Risk Levels, Increased Spread in Cases

(COLUMBUS, Ohio)—Ohio Governor Mike DeWine and Lt. Governor Jon Husted today provided the following updates on Ohio’s response to the COVID-19 pandemic.

UPDATED COUNTY RISK LEVELS

Governor DeWine today released Ohio’s updated Public Health Advisory System map. New health data compiled by the Ohio Department of Health found that 29 counties currently have a very high risk of exposure and spread (Level 3):

Adams, Butler, Clark, Cuyahoga, Fayette, Franklin, Greene, Guernsey, Hamilton, Highland, Lawrence, Licking, Lucas, Madison, Mahoning, Marion, Mercer, Montgomery, Muskingum, Pike, Portage, Putnam, Richland, Ross, Stark, Summit, Scioto, Union, and Warren

“We have 70 counties that are either red or high incidence.

Read full story